Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Phyllis Chan

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Pharmaceutical Research|January 26, 2020
Correction to: Population Pharmacokinetics, Efficacy Exposure-response Analysis, and Model-based Meta-analysis of Fenebrutinib in Subjects with Rheumatoid ArthritisPhyllis Chan, Jiajie Yu, Leslie Chinn, et al.
Cancer Chemotherapy and Pharmacology|April 27, 2021
Time-dependent population PK models of single-agent atezolizumab in patients with cancerMathilde Marchand, Rong Zhang, Phyllis Chan, et al.
The AAPS Journal|April 28, 2022
Tumor Growth Inhibition-Overall Survival (TGI-OS) Model for Subgroup Analysis Based on Post-Randomization Factors: Application for Anti-drug Antibody (ADA) Subgroup Analysis of Atezolizumab in the IMpower150 StudyKenta Yoshida, Phyllis Chan, Mathilde Marchand, et al.
The AAPS Journal|December 23, 2025
Revisiting the Anti-Drug Antibody Assay Drug Tolerance of a Commercial Biological ProductJames Zanghi, Nancy Yu, Benjamin T Andrews, et al.
American Indian and Alaska Native Mental Health Research (Online)|June 30, 2026
Systematic Review and Meta-Analysis of Anxiety and Depression Among American Indian and Alaska Native Adolescents in the United StatesPhyllis Chan, Abdelrahman M Makram, Valentín Quiroz de la Sierra, et al.
Molecular Pharmaceutics|September 16, 2022
C-Terminal Lysine Processing of IgG in Human Suction Blister Fluid: Implications for Subcutaneous AdministrationLuladey Ayalew, Phyllis Chan, Zhilan Hu, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 17, 2026
Model-Based Meta-Analysis of Overall Survival in Vulnerable Platinum-Ineligible NSCLC PopulationsJoseph Chen, Russ Wada, Nancy Zhang, et al.
Journal of Clinical Pharmacology|July 22, 2014
Derivation of Phase 3 dosing for peginterferon lambda-1a in chronic hepatitis C, Part 2: Exposure-response analyses for efficacy and safety variablesMatthew Hruska, Xiaodong Wang, Phyllis Chan, et al.
Journal of Clinical Pharmacology|July 22, 2014
Derivation of Phase 3 dosing for peginterferon lambda-1a in chronic hepatitis C, Part 1: Modeling optimal treatment duration and sustained virologic response ratesXiaodong Wang, Matthew Hruska, Phyllis Chan, et al.
Asia-Pacific Psychiatry : Official Journal of the Pacific Rim College of Psychiatrists|August 24, 2016
Lost in transition: A review of the unmet need of patients with attention deficit/hyperactivity disorder transitioning to adulthoodTamás Treuer, Kwok Ling Phyllis Chan, Bung Nyun Kim, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Pharmaceutical Research|January 26, 2020
Correction to: Population Pharmacokinetics, Efficacy Exposure-response Analysis, and Model-based Meta-analysis of Fenebrutinib in Subjects with Rheumatoid ArthritisPhyllis Chan, Jiajie Yu, Leslie Chinn, et al.
Cancer Chemotherapy and Pharmacology|April 27, 2021
Time-dependent population PK models of single-agent atezolizumab in patients with cancerMathilde Marchand, Rong Zhang, Phyllis Chan, et al.
The AAPS Journal|April 28, 2022
Tumor Growth Inhibition-Overall Survival (TGI-OS) Model for Subgroup Analysis Based on Post-Randomization Factors: Application for Anti-drug Antibody (ADA) Subgroup Analysis of Atezolizumab in the IMpower150 StudyKenta Yoshida, Phyllis Chan, Mathilde Marchand, et al.
The AAPS Journal|December 23, 2025
Revisiting the Anti-Drug Antibody Assay Drug Tolerance of a Commercial Biological ProductJames Zanghi, Nancy Yu, Benjamin T Andrews, et al.
American Indian and Alaska Native Mental Health Research (Online)|June 30, 2026
Systematic Review and Meta-Analysis of Anxiety and Depression Among American Indian and Alaska Native Adolescents in the United StatesPhyllis Chan, Abdelrahman M Makram, Valentín Quiroz de la Sierra, et al.
Molecular Pharmaceutics|September 16, 2022
C-Terminal Lysine Processing of IgG in Human Suction Blister Fluid: Implications for Subcutaneous AdministrationLuladey Ayalew, Phyllis Chan, Zhilan Hu, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 17, 2026
Model-Based Meta-Analysis of Overall Survival in Vulnerable Platinum-Ineligible NSCLC PopulationsJoseph Chen, Russ Wada, Nancy Zhang, et al.
Journal of Clinical Pharmacology|July 22, 2014
Derivation of Phase 3 dosing for peginterferon lambda-1a in chronic hepatitis C, Part 2: Exposure-response analyses for efficacy and safety variablesMatthew Hruska, Xiaodong Wang, Phyllis Chan, et al.
Journal of Clinical Pharmacology|July 22, 2014
Derivation of Phase 3 dosing for peginterferon lambda-1a in chronic hepatitis C, Part 1: Modeling optimal treatment duration and sustained virologic response ratesXiaodong Wang, Matthew Hruska, Phyllis Chan, et al.
Asia-Pacific Psychiatry : Official Journal of the Pacific Rim College of Psychiatrists|August 24, 2016
Lost in transition: A review of the unmet need of patients with attention deficit/hyperactivity disorder transitioning to adulthoodTamás Treuer, Kwok Ling Phyllis Chan, Bung Nyun Kim, et al.
Pageof 4